We read with interest the article by Bischoff et al, in which they describe detection of influenza virus in aerosols around hospitalized patients with influenza virus infection who were receiving routine care \[[@JIU127C1]\]. As the authors note, current World Health Organization and Centers for Disease Control and Prevention guidelines for protection of healthcare professionals from influenza virus infection rely on the supposition that, under routine conditions, most transmission occurs via large droplets, rather than via small-particle aerosols \[[@JIU127C2], [@JIU127C3]\]. Under these guidelines, aerosol transmission is presumed to be limited to certain aerosol-generating procedures (AGPs), for which higher-level respiratory protection is recommended. The designation of AGPs has been made in large part by extrapolation from epidemiologic studies of outbreaks of other respiratory infections, such as tuberculosis and SARS coronavirus infection \[[@JIU127C4]\]. Whether such procedures are uniquely associated with generation of potentially infectious aerosols has not been established.

As part of a pilot study, we recently enrolled patients with and those without respiratory infections who were undergoing potential AGPs at a tertiary-care hospital. All patients provided written informed consent. We included patients with documented influenza virus infection during periods when they were undergoing mechanical ventilation and/or during periods when they were breathing on their own. We sampled air within 0.91 m (3 feet) and 1.83 m (6 feet) of the patient and outside the room for 3.25 hours, using National Institute for Occupational Safety and Health 2-stage aerosol samplers \[[@JIU127C5]\]. Aerosol sampling was also performed for 1 to several minutes near the patient\'s mouth, using closed-faced filter cassettes during extubation, suctioning, and use of an incentive spirometer. Influenza virus RNA copy number was determined by polymerase chain reaction (PCR), and the mean value of 2 replicates was used in analysis.

Variability in influenza virus RNA--laden aerosol generation was evident. The experience of one patient with influenza diagnosed on hospital day 1 by PCR of bronchoalveolar lavage fluid is informative ([Table 1](#JIU127TB1){ref-type="table"}). On hospital day 2, we obtained samples while the patient was breathing with the assistance of a mechanical ventilator. On hospital day 3, we obtained samples during extubation and subsequently while the patient was breathing on his own. On hospital day 4, we again obtained samples while the patient was breathing on his own. On each day, influenza virus RNA was detected in particles of respirable size, but a relationship to what we considered to be potential AGPs (mechanical ventilation, suctioning, extubation, and use of an incentive spirometer) was not evident. Indeed, potential respiratory exposures to healthcare professionals in the room appeared highest on hospital day 4, when the patient was breathing on his own and care was routine. Interestingly, the highest concentration of influenza virus RNA copies observed during these 3 days of sampling occurred on hospital day 3, outside of the patient\'s room. Although genetic comparison to the patient\'s virus was not performed, the pattern suggested a source of influenza virus other than the patient and underscored the challenges of studying and controlling influenza virus transmission in the hospital setting.

###### 

Results of Air Sampling Near a Patient With Influenza

  Sampler Location, Height, Stage            Influenza A Virus Load, Copies/m^3^ of Air                  
  ------------------------------------------ -------------------------------------------- -------------- --------------
  Head of bed^a^                                                                                         
   1.52 m                                                                                                
    First (≥4 µm)                            Not detected                                 Not detected   826
    Second (1--4 µm)                         216                                          Not detected   983
    Filter (\<1 µm)                          Not detected                                 112            Not detected
     Total respirable (\<4 µm)               216                                          112            983
   1.02 m                                                                                                
    First (≥4 µm)                            Not detected                                 Not detected   Not detected
    Second (1--4 µm)                         414                                          Not detected   Not detected
    Filter (\<1 µm)                          Not detected                                 Not detected   Not detected
     Total respirable (\<4 µm)               414                                          Not detected   Not detected
  Right of bed (1.83 m from patient)                                                                     
   1.52 m                                                                                                
    First (≥4 µm)                            32 770                                       Not detected   26
    Second (1--4 µm)                         Not detected                                 Not detected   29 887
    Filter (\<1 µm)                          Not detected                                 Not detected   Not detected
     Total respirable (\<4 µm)               Not detected                                 Not detected   29 887
   1.02 m                                                                                                
    First (≥4 µm)                            Not detected                                 Not detected   Not detected
    Second (1--4 µm)                         Not detected                                 Not detected   2085
    Filter (\<1 µm)                          Not detected                                 Not detected   Not detected
     Total respirable (\<4 µm)               Not detected                                 Not detected   2085
  Outside room                                                                                           
   1.52 m                                                                                                
    First (≥4 µm)                            Not detected                                 Not detected   Not detected
    Second (1--4 µm)                         Not detected                                 3844           44
    Filter (\<1 µm)                          Not detected                                 Not detected   Not detected
     Total respirable (\<4 µm)               Not detected                                 3844           44
   1.02 m                                                                                                
    First (≥4 µm)                            Not detected                                 Not detected   Not detected
    Second (1--4 µm)                         Not detected                                 329 152        141
    Filter (\<1 µm)                          Not detected                                 Not detected   53
     Total respirable (\<4 µm)               Not detected                                 329 152        194
  Near patient mouth during suctioning                                                                   
   0 m                                                                                                   
    Filter                                   Not detected                                 Not done       Not done
  Near patient mouth during extubation                                                                   
   0 m                                                                                                   
    Filter                                   Not done                                     Not detected   Not done
  Near patient mouth during spirometer use                                                               
   0 m                                                                                                   
    Filter                                   Not done                                     2913           Not done

On hospital day 2, patient was breathing with the assistance of a mechanical ventilator. On hospital days 3 and 4, patient was breathing on his own. The lower limits of detection and quantification by quantitative polymerase chain reaction were 10 and 15 copies, respectively.

The sampler was located behind the patient\'s head. This location was chosen to limit interference with clinical activities, but it may have contributed to the relatively low number of influenza A virus copies in the larger stage (≥4 µm).

Bischoff et al found that the majority of influenza virus RNA was contained in small particles. This observation corroborates previous work \[[@JIU127C5]--[@JIU127C7]\] and raises the possibility that aerosol transmission of influenza virus may occur during routine patient care \[[@JIU127C8]\]. Looking forward, by better characterizing the risk of infection when influenza virus--laden aerosols are generated, such as verifying the infectivity of virus found in small particles and/or demonstrating an increased risk of influenza virus infection among healthcare professionals due to small particle aerosols, future studies may prompt a reconsideration of current guidelines for protecting such individuals from influenza virus infection. Yet as our experience suggests, multiple sources of influenza virus are possible in healthcare settings, and some of these sources (whether they are patients, fellow healthcare workers, or visitors with undiagnosed infection) will go unrecognized. Thus, use of preventive measures that do not require source recognition, such as vaccination, will remain of paramount importance.
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